BioCorteX
Cures neurodegenerative diseases by hacking the microbiome and delivering enhanced therapeutics as soon as possible.
Launch date
Employees
Market cap
-
Enterprise valuation
€18—27m (Dealroom.co estimates Mar 2023.)
Company register number 13287534
London England (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $5.0m | Seed | |
| Total Funding | €4.5m | ||
Related Content
Recent News about BioCorteX
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.